Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 11, 2015
0Patent Application Number
138021720
Date Filed
March 13, 2013
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.